Dr Valon Llabjani

PhD in Biological sciences

CEO

United Kingdom

Research Interests

co-culture, Liver pre-clinical drug screening, barrier organs, ADME, Hepatotoxicity, 3D cell culture

Revivocell develops next dimension cell culture technology to improve research in life science and enhance pre-clinical screening in drug discovery. It’s our passion to provide technology that enables researchers to replicate the interactions of multiple organs in one platform that is easy to use and can closely mimic real life scenarios, whilst reducing animal testing. Our novel platform, CELLBLOKS® is first of its kind, in-vitro modular “Plug and Play” platform that allows researchers to build multiple cell type complex body-like models using "cell-blocks".